DEXACORT

LOE Approaching

dexamethasone sodium phosphate

UCB Pharma
NDAINHALATIONAEROSOL, METERED
Approved
Sep 1962
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
2

Indications (11)

Rheumatoid arthritispsoriasisasthmaAtopic dermatitisUlcerative colitismultiple sclerosisanemiaLeukemialymphomaof severeincapacitating allergic conditions intractable to adequate trials of conventional treatment in: Bronchial asthma

Clinical Trials (2)

NCT02770807Phase 3Completed

Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Telangiectasia Patients

Started Mar 2017
176 enrolled
Nervous System DiseaseGenetic Syndrome
NCT01255358Phase 2Completed

Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Teleangiectasia Patients

Started Feb 2011
22 enrolled
Nervous System DisorderGenetic Syndrome
Company
UP
UCB Pharma
Belgium - Brussels
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers